Combining genetic markers and clinical risk factors improves the risk assessment of impaired glucose metabolism

References

• International Diabetes Federation. Diabetes Atlas 2007. Available from: www.eatlas.idf.org (accessed 1 February 2007).
   Google Scholar
• Cowie CC, Rust KF, Byrd-Holt DD, Eberhardt MS, Flegal KM, Engelgau MM, . Prevalence of diabetes and impaired fasting glucose in adults in the U. S. population: National Health And Nutrition Examination Survey 1999–2002. Diabetes Care.2006;29:1263–8.
   PubMed Web of Science ®Google Scholar
• Harris MI, Eastman RC. Early detection of undiagnosed diabetes mellitus: a US perspective. Diabetes Metab Res Rev.2000;16:230–6.
   PubMed Web of Science ®Google Scholar
• Chiasson JL, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M. Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet.2002;359:2072–7.
   PubMed Web of Science ®Google Scholar
• Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, . Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med.2002;346:393–403.
   PubMed Web of Science ®Google Scholar
• Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hama-lainen H, Ilanne-Parikka P, . Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med.2001;344: 1343–50.
   PubMed Web of Science ®Google Scholar
• Schwarz PE, Li J, Lindstrom J, Tuomilehto J. Tools for predicting the risk of type 2 diabetes in daily practice. Horm Metab Res.2009;41:86–97.
   PubMed Web of Science ®Google Scholar
• Freeman H, Cox RD. Type-2 diabetes: A cocktail of genetic discovery. Hum Mol Genet. 2006; 15 Spec No 2:R202–9.
   PubMedGoogle Scholar
• Weedon MN, McCarthy MI, Hitman G, Walker M, Groves CJ, Zeggini E, . Combining information from common type 2 diabetes risk polymorphisms improves disease prediction. PLoS Med. 2006;3:e374.
   PubMed Web of Science ®Google Scholar
• Lyssenko V, Almgren P, Anevski D, Orho-Melander M, Sjogren M, Saloranta C, . Genetic prediction of future type 2 diabetes. PLoS Med. 2005;2:e345.
   Web of Science ®Google Scholar
• Janssens AC, Gwinn M, Khoury MJ, Subramonia-Iyer S. Does genetic testing really improve the prediction of future type 2 diabetes? PLoS Med. 2006;3:ell4; author reply e27.
   Google Scholar
• Vaxillaire M, Veslot J, Dina C, Proenca C, Cauchi S, Charpentier G, . Impact of common type 2 diabetes risk polymorphisms in the DESIR prospective study. Diabetes.2008;57:244–54.
   PubMed Web of Science ®Google Scholar
• Gudmundsson J, Sulem P, Steinthorsdottir V, Bergthorsson JT, Thorleifsson G, Manolescu A, .Two variants on chromosome 17 confer prostate cancer risk, and the one inTCF2 protects against type 2 diabetes. Nat Genet.2007;39: 977–83.
   PubMed Web of Science ®Google Scholar
• Saxena R, Voight BF, Lyssenko V, Burn NP, de Bakker PI, Chen H, . Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science.2007;316:1331–6.
   PubMed Web of Science ®Google Scholar
• Scott LJ, Mohlke KL, Bonnycastle LL, Wilier CJ, Li Y, Duren WL, . A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science.2007;316:1341–5.
   PubMed Web of Science ®Google Scholar
• Sladek R, Rocheleau G, Rung J, Dina C, Shen L, Serre D, . A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature.2007;445:881–5.
   PubMed Web of Science ®Google Scholar
• Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature.2007;447:661–78.
   PubMed Web of Science ®Google Scholar
• Zeggini E, Scott LJ, Saxena R, Voight BF, Marchini JL, Hu T, . Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nat Genet.2008;40:638–45.
   PubMed Web of Science ®Google Scholar
• Zeggini E, Weedon MN, Lindgren CM, Frayling TM, Elliott KS, Lango H, . Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science. 2007;316:1336–41.
   PubMed Web of Science ®Google Scholar
• Lango H, Palmer CN, Morris AD, Zeggini E, Hattersley AT, McCarthy MI, . Assessing the combined impact of 18 common genetic variants of modest effect sizes on type 2 diabetes risk. Diabetes.2008;57:3129–35.
   PubMed Web of Science ®Google Scholar
• Lyssenko V, Jonsson A, Almgren P, Pulizzi N, Isomaa B, Tuomi T, . Clinical risk factors, DNA variants, and the development of type 2 diabetes. N Engl J Med.2008;359: 2220–32.
   PubMed Web of Science ®Google Scholar
• Meigs JB, Shrader P, Sullivan LM, McAteer JB, Fox CS, Dupuis J, . Genotype score in addition to common risk factors for prediction of type 2 diabetes. N Engl J Med.2008;359:2208–19.
   PubMed Web of Science ®Google Scholar
• van Hoek M, Dehghan A, Witteman JC, van Duijn CM, Uitterlinden AG, Oostra BA, . Predicting type 2 diabetes based on polymorphisms from genome-wide association studies: a population-based study. Diabetes.2008;57: 3122–8.
   PubMed Web of Science ®Google Scholar
• Myake K, Yang W, Hara K, Yasuda K, Horikawa Y, Osawa H, . Construction of a prediction model for type 2 diabetes mellitus in the Japanese population based on 11 genes with strong evidence of the association. J Hum Genet. 2009;54:236–1.
   Google Scholar
• Bouchard C. Genetic epidemiology, association and sib-pair linkage: results from the Quebec Family Study. Bray GA, Ryan DH, editors. Molecular and genetic aspects of obesity. Baton Rouge: Louisiana State University Press; 1996. p. 470–81.
   Google Scholar
• Perusse L, Rice T, Bouchard C, Vogler GP, Rao DC. Cardiovascular risk factors in a French-Canadian population: resolution of genetic and familial environmental effects on blood pressure by using extensive information on environmental correlates. Am J Hum Genet.1989;45: 240–51.
   PubMed Web of Science ®Google Scholar
• Rice T, Nadeau A, Perusse L, Bouchard C, Rao DC. Familial correlations in the Quebec family study: cross-trait familial resemblance for body fat with plasma glucose and insulin. Diabetologia.1996;39:1357–64.
   PubMedGoogle Scholar
• World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications. Geneva: World Health Organization; 1999.
   Google Scholar
• Chagnon YC, Borecki IB, Perusse L, Roy S, Lacaille M, Chagnon M, . Genome-wide search for genes related to the fat-free body mass in the Quebec family study. Metabolism.2000;49:203–7.
   Google Scholar
• Livak KJ. Allelic discrimination using fluorogenic probes and the 5’ nuclease assay. Genet Anal.1999;14:143–9.
   PubMedGoogle Scholar
• O’Connell JR, Weeks DE. PedCheck: a program for identification of genotype incompatibilities in linkage analysis. Am JHum Genet.1998;63:259–66.
   PubMed Web of Science ®Google Scholar
• Devlin B, Risch N. A comparison of linkage disequilibrium measures for fine-scale mapping. Genomics.1995;29: 311–22.
   PubMed Web of Science ®Google Scholar
• DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44:837–45.
   PubMed Web of Science ®Google Scholar
• Hertel JK, Johansson S, Raeder H, Midthjell K, Lyssenko V, Groop L, . Genetic analysis of recently identified type 2 diabetes loci in 1,638 unselected patients with type 2 diabetes and 1,858 control participants from a Norwegian population-based cohort (the HUNT study). Diabetologia.2008;51:971–7.
   Web of Science ®Google Scholar
• Horikawa Y, Myake K, Yasuda K, Enya M, Hirota Y, Yamagata K, . Replication of genome-wide association studies of type 2 diabetes susceptibility in Japan. J Clin Endocrinol Metab.2008;93:3136–41.
   Google Scholar
• Lee YH, Rang ES, Kim SH, Han SJ, Kim CH, Kim HJ, . Association between polymorphisms in SLC30A8, HHEX, CDKN2A/B, IGF2BP2, FTO, WFS1, CDKAL1, KCNQ1 and type 2 diabetes in the Korean population. J Hum Genet.2008;53:991–8.
   PubMed Web of Science ®Google Scholar
• Omori S, Tanaka Y, Takahashi A, Hirose H, Kashiwagi A, Kaku K, . Association of CDKAL1, IGF2BP2, CDKN2A/B, HHEX, SLC30A8, and KCNJ11 with susceptibility to type 2 diabetes in a Japanese population. Diabetes.2008;57:791–5.
   PubMed Web of Science ®Google Scholar
• Tabara Y, Osawa H, Kawamoto R, Onuma H, Shimizu I, Mki T, . Replication study of candidate genes associated with type 2 diabetes based on genome-wide screening. Diabetes.2009;58:493–8.
   PubMed Web of Science ®Google Scholar
• Cauchi S, Meyre D, Durand E, Proenca C, Marre M, Hadjadj S, . Post genome-wide association studies of novel genes associated with type 2 diabetes show gene-gene interaction and high predictive value. PLoS One. 2008; 3:e2031.
   Web of Science ®Google Scholar
• Janssens AC, Pardo MC, Steyerberg EW, van Duijn CM. Revisiting the clinical validity of multiplex genetic testing in complex diseases. Am J Hum Genet.2004;74:585–8.
   PubMed Web of Science ®Google Scholar
• Janssens AC, Aulchenko YS, Elefante S, Borsboom GJ, Steyerberg EW, van Duijn CM. Predictive testing for complex diseases using multiple genes: fact or fiction? Genet Med. 2006;8:395–400.
   PubMed Web of Science ®Google Scholar
• Yang Q, Khoury MJ, Friedman J, Little J, Flanders WD. How many genes underlie the occurrence of common complex diseases in the population? Int J Epidemiol. 2005;34:1129–37.
   PubMed Web of Science ®Google Scholar
• Lu Q, Elston RC. Using the optimal receiver operating characteristic curve to design a predictive genetic test, exemplified with type 2 diabetes. Am J Hum Genet.2008;82: 641–51.
   PubMed Web of Science ®Google Scholar